ロード中...
Antitumor effects of regorafenib and sorafenib in preclinical models of hepatocellular carcinoma
The purpose of this study was to investigate the antitumor activity of regorafenib and sorafenib in preclinical models of HCC and to assess their mechanism of action by associated changes in protein expression in a HCC-PDX mouse model. Both drugs were administered orally once daily at 10 mg/kg (rego...
保存先:
| 出版年: | Oncotarget |
|---|---|
| 主要な著者: | , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Impact Journals LLC
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5739799/ https://ncbi.nlm.nih.gov/pubmed/29291014 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22334 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|